Ara
Toplam kayıt 6, listelenen: 1-6
AKDOĞAN, Ali; ERDEN, Abdulsamet; FIRAT ŞENTÜRK, Esra; KILIÇ, Levent; SARI, Alper; ARMAĞAN, Berkan; KARADAĞ, Ömer; KİRAZ, Sedat
(2019)
Background/aim Abnormal capillaroscopic findings have been reported in vasculitic syndromes such as Behçet’s disease, Henoch–Schönlein purpura, and Wegener’s granulomatosis. This study was conducted to define the capillaroscopic ...
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
(TÜBİTAK, 2020-02-13)
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...
Interferon alpha might be an alternative therapeutic choice for refractory Neuro-Behçet's disease
(Elsevier, 2019-01-06)
Comments on Neuro-Behcet's Disease
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data
(TÜBİTAK, 2020-01-09)
Background/aim: Neonatal lupus erythematosus (NLE) is an autoimmune syndrome caused by transplacental transmission of maternal autoantibodies, often with devastating consequences. The objective of this systematic literature ...
Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry
(Springer, 2019-01-21)
Objective
Psoriatic Arthritis Impact of Disease 12-item questionnaire (PsAID-12) has been developed to be used in psoriatic arthritis in daily practice. The aim of the present study was to assess the change values of ...
Adalimumab as Treatment for Venous Thrombosis in Behçet's Syndrome: Comment on the Article by Emmi et al
(Wıley, 2019-03-02)
We read with interest the article by Emmi et al 1 regarding the effect of adalimumab (ADA)–based treatment versus disease‐modifying antirheumatic drug (DMARD) therapy for venous thrombosis in Behçet's syndrome (BS). Their ...